{"id":1980,"date":"2026-09-15T19:12:24","date_gmt":"2026-09-16T00:12:24","guid":{"rendered":"https:\/\/www.surfacide.com\/?p=1980"},"modified":"2026-09-15T19:12:28","modified_gmt":"2026-09-16T00:12:28","slug":"what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26","status":"publish","type":"post","link":"https:\/\/www.surfacide.com\/es\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/","title":{"rendered":"Lo que los l\u00edderes sanitarios deben saber sobre la radiaci\u00f3n UV: 3 conclusiones de AHE Exchange26"},"content":{"rendered":"

En la reciente cumbre Exchange26 de la Asociaci\u00f3n para el Entorno Sanitario (AHE, por sus siglas en ingl\u00e9s) celebrada en Nueva Orleans, una importante sesi\u00f3n plenaria titulada "Dispositivos UV en el entorno sanitario: consideraciones que los profesionales de servicios ambientales deben conocer" fue un elemento central del programa de Tecnolog\u00eda e Innovaci\u00f3n.<\/p>\n\n\n\n

A medida que los centros sanitarios eval\u00faan cada vez m\u00e1s la luz ultravioleta y otras tecnolog\u00edas complementarias para la limpieza y desinfecci\u00f3n ambiental, comprender el marco regulatorio se ha vuelto esencial. Durante la sesi\u00f3n de AHE, expertos que representan las perspectivas regulatoria, cl\u00ednica y sanitaria analizaron las implicaciones de la supervisi\u00f3n de la FDA para los fabricantes, los proveedores de atenci\u00f3n m\u00e9dica y los profesionales responsables de evaluar estas tecnolog\u00edas. El debate aport\u00f3 informaci\u00f3n valiosa sobre la reducci\u00f3n microbiana en habitaciones completas, la evidencia necesaria para la autorizaci\u00f3n de la FDA y los riesgos asociados con las afirmaciones no autorizadas o fuera de indicaci\u00f3n.<\/p>\n\n\n\n

    \n
  1. La reducci\u00f3n microbiana en habitaciones completas es una categor\u00eda de dispositivos m\u00e9dicos regulada por la FDA.<\/strong><\/li>\n<\/ol>\n\n\n\n

    Durante el panel de discusi\u00f3n, Christopher Dugard, director de la Divisi\u00f3n de Dispositivos para el Control de Infecciones de la FDA, perteneciente a la Oficina de Dispositivos Quir\u00fargicos y para el Control de Infecciones, aclar\u00f3 que la reducci\u00f3n microbiana en habitaciones completas es una categor\u00eda distinta de dispositivo m\u00e9dico de Clase II, establecida por la agencia en 2023. Cuando un dispositivo que utiliza tecnolog\u00eda UV o qu\u00edmica tiene como objetivo reducir la carga microbiana en las superficies de los dispositivos m\u00e9dicos tras la limpieza y desinfecci\u00f3n, est\u00e1 sujeto a los requisitos de la FDA. Las afirmaciones de que un dispositivo reduce o previene infecciones, incluidas las infecciones asociadas a la atenci\u00f3n m\u00e9dica, tambi\u00e9n entran dentro del \u00e1mbito de los dispositivos m\u00e9dicos y requieren evidencia cl\u00ednica apropiada.<\/p>\n\n\n\n

    Es importante destacar que la discusi\u00f3n reforz\u00f3 la idea de que el registro o la supervisi\u00f3n de la EPA no lo hace<\/em> <\/strong>Sustituir la autorizaci\u00f3n de la FDA cuando un producto est\u00e1 destinado y comercializado para estos usos como dispositivo m\u00e9dico. Para las organizaciones sanitarias que eval\u00faan tecnolog\u00edas UV, la cuesti\u00f3n relevante no es simplemente si un dispositivo tiene registro de la EPA, sino si est\u00e1 autorizado por la FDA para el uso que la instituci\u00f3n pretende darle.\u00a0<\/p>\n\n\n\n

    Nuestra conclusi\u00f3n: si su dispositivo est\u00e1 dise\u00f1ado para lograr la reducci\u00f3n microbiana en otro dispositivo m\u00e9dico o superficie, por defecto estar\u00e1 regulado por la FDA.<\/strong><\/p>\n\n\n\n

      \n
    1. La autorizaci\u00f3n de la FDA representa una revisi\u00f3n sustancial, no simplemente una etiqueta de marketing.<\/strong><\/li>\n<\/ol>\n\n\n\n

      Durante la sesi\u00f3n tambi\u00e9n se abord\u00f3 que el proceso de autorizaci\u00f3n de la FDA exige que los fabricantes de dispositivos realicen pruebas de rendimiento rigurosas para demostrar la eficacia en la reducci\u00f3n de microorganismos, la seguridad del dispositivo, el etiquetado, el uso previsto y los controles especiales aplicables. Para la v\u00eda 510(k), los fabricantes deben demostrar que su dispositivo es al menos tan seguro y eficaz como el dispositivo de referencia. La agencia hizo referencia a esto como el cumplimiento de la equivalencia sustancial.<\/p>\n\n\n\n

      La sesi\u00f3n tambi\u00e9n aclar\u00f3 que la reducci\u00f3n de 2 log demostrada por los dispositivos autorizados hasta la fecha no es un punto de referencia de marketing arbitrario. Se estableci\u00f3 a trav\u00e9s de la categor\u00eda de Reducci\u00f3n Microbiana de Habitaci\u00f3n Completa de la FDA y el dispositivo de referencia. En las peores condiciones de prueba revisadas por la FDA, estos dispositivos lograron consistentemente al menos una reducci\u00f3n microbiana de 2 log en toda la habitaci\u00f3n tratada, incluso contra C. difficile<\/em> esporas. Esto representa el rendimiento m\u00ednimo demostrado en condiciones dif\u00edciles, no la reducci\u00f3n m\u00e1xima que pueden lograr los dispositivos.<\/p>\n\n\n\n

       De hecho, en sus ciclos validados y como parte de las pruebas de su curva de eliminaci\u00f3n optimizada, realizadas para la revisi\u00f3n previa a la comercializaci\u00f3n por parte de la FDA, Surfacide Helios+ proporciona una dosis de hasta 1300 mJ\/cm2 o 1,3 J\/cm2 a organismos multirresistentes con mayor resistencia, como C. difficile, para lograr la reducci\u00f3n microbiana en toda la habitaci\u00f3n.<\/p>\n\n\n\n

      Los panelistas enfatizaron adem\u00e1s que la reducci\u00f3n microbiana en habitaciones completas tiene como objetivo complementar, no reemplazar, la limpieza y desinfecci\u00f3n manuales. En conjunto, estos requisitos brindan a las organizaciones de atenci\u00f3n m\u00e9dica un marco coherente y basado en evidencia para comparar tecnolog\u00edas que pueden parecer similares en una presentaci\u00f3n comercial, pero que no han sido sometidas a la misma revisi\u00f3n regulatoria.<\/p>\n\n\n\n

        \n
      1. Las afirmaciones no autorizadas y fuera de las indicaciones aprobadas generan un riesgo significativo.<\/strong><\/li>\n<\/ol>\n\n\n\n

        La exfuncionaria de la FDA, Liz Claverie, hizo hincapi\u00e9 durante la sesi\u00f3n en que etiquetar o comercializar un producto como dispositivo m\u00e9dico sin la autorizaci\u00f3n requerida por la FDA puede constituir una pr\u00e1ctica de etiquetado enga\u00f1oso seg\u00fan la ley federal. Asimismo, advirti\u00f3 que promocionar o utilizar un dispositivo para fines distintos a los autorizados en su etiquetado puede exponer tanto al fabricante como al profesional sanitario a graves consecuencias.<\/p>\n\n\n\n

        \n

        \u201cEl uso de un dispositivo m\u00e9dico fuera de las indicaciones autorizadas supone un importante riesgo legal y regulatorio para el profesional sanitario. As\u00ed que no se trata solo de usted. Ahora est\u00e1 poniendo en riesgo al profesional sanitario, y existe una mayor responsabilidad por negligencia m\u00e9dica, sanciones regulatorias por parte de organismos como mi antiguo organismo, la FDA, los colegios m\u00e9dicos estatales, la p\u00e9rdida de la acreditaci\u00f3n institucional, etc.\u201d<\/strong><\/p>\n<\/blockquote>\n\n\n\n

        Claverie tambi\u00e9n se\u00f1al\u00f3 que pueden surgir riesgos incluso cuando un dispositivo cuenta con el etiquetado adecuado si un vendedor lo promociona verbalmente para un uso no autorizado. Como recalc\u00f3 durante la sesi\u00f3n, la promoci\u00f3n de usos no autorizados no es simplemente una cuesti\u00f3n de marketing. Puede exponer a la organizaci\u00f3n de atenci\u00f3n m\u00e9dica que conf\u00eda en esas afirmaciones a importantes riesgos legales, regulatorios e institucionales.<\/p>\n\n\n\n

        Chris Dugard explic\u00f3 el valor m\u00e1s amplio de la regulaci\u00f3n: genera responsabilidad y ofrece mayor garant\u00eda de que las afirmaciones de los fabricantes son veraces y est\u00e1n respaldadas por evidencia. Sin esa supervisi\u00f3n, las empresas podr\u00edan simplemente hacer afirmaciones cada vez m\u00e1s impresionantes, dejando a las organizaciones de atenci\u00f3n m\u00e9dica sin una base confiable para evaluar o comparar tecnolog\u00edas.<\/p>\n\n\n\n

        En general, la sesi\u00f3n reforz\u00f3 la idea de que se requiere la autorizaci\u00f3n de la FDA para cualquier dispositivo que afirme reducir la presencia microbiana en toda una habitaci\u00f3n, y que la aprobaci\u00f3n de la FDA es mucho m\u00e1s que un hito regulatorio.<\/strong> Esto brinda a las organizaciones de atenci\u00f3n m\u00e9dica mayor confianza en que el uso previsto, el rendimiento y las afirmaciones de seguridad de un dispositivo han sido sometidos a una revisi\u00f3n exhaustiva. Para los l\u00edderes de atenci\u00f3n m\u00e9dica que eval\u00faan tecnolog\u00edas de reducci\u00f3n microbiana en habitaciones completas, la debida diligencia debe comenzar con la confirmaci\u00f3n de la autorizaci\u00f3n de la FDA y continuar asegur\u00e1ndose de que cada afirmaci\u00f3n, tanto escrita como verbal, se ajuste al etiquetado autorizado del dispositivo. En una categor\u00eda regulada, estas distinciones son importantes para tomar decisiones de compra informadas, garantizar la seguridad del paciente, la responsabilidad organizacional y mitigar el riesgo institucional. <\/p>\n\n\n\n

        Enhorabuena a AHE por traer esta oportuna sesi\u00f3n educativa a Exchange26 y ayudar a aclarar un tema importante y a menudo mal entendido.<\/p>","protected":false},"excerpt":{"rendered":"

        At the recent Association for the Health Care Environment (AHE) Exchange26 Summit in New Orleans, a major General Session titled “UV Devices in the Healthcare Environment: Considerations EVS Professionals Should Know” was a central feature of the Technology & Innovation track. As healthcare facilities increasingly evaluate UV and other adjunctive technologies to supplement environmental cleaning […]<\/p>\n

        Read More… from What Healthcare Leaders Need to Know About UV: 3 Takeaways from AHE Exchange26<\/span><\/a><\/p>\n","protected":false},"author":10,"featured_media":1982,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"page-templates\/custom-blog.php","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[8],"tags":[32,28,27,29,33,31],"class_list":["post-1980","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-ahe-exchange26","tag-environmental-services","tag-evs","tag-patient-safety","tag-uv-regulation","tag-whole-room-microbial-reduction"],"acf":[],"yoast_head":"\nWhat Healthcare Leaders Need to Know About UV: 3 Takeaways from AHE Exchange26 - Surfacide<\/title>\n<meta name=\"description\" content=\"Show appreciation for environmental service employees by nominating them for our Surfacide Shining Star Scholarship Award.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.surfacide.com\/es\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What Healthcare Leaders Need to Know About UV: 3 Takeaways from AHE Exchange26\" \/>\n<meta property=\"og:description\" content=\"Show appreciation for environmental service employees by nominating them for our Surfacide Shining Star Scholarship Award.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.surfacide.com\/es\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/\" \/>\n<meta property=\"og:site_name\" content=\"Surfacide\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/surfacide\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-16T00:12:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-16T00:12:28+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.surfacide.com\/wp-content\/uploads\/2026\/09\/AHE-Panel.png\" \/>\n\t<meta property=\"og:image:width\" content=\"706\" \/>\n\t<meta property=\"og:image:height\" content=\"613\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gina\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SurfacideUVC\" \/>\n<meta name=\"twitter:site\" content=\"@SurfacideUVC\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/\"},\"author\":{\"name\":\"Gina\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/person\\\/386a69d9460c5d653f83ad3b124557e9\"},\"headline\":\"What Healthcare Leaders Need to Know About UV: 3 Takeaways from AHE Exchange26\",\"datePublished\":\"2026-09-16T00:12:24+00:00\",\"dateModified\":\"2026-09-16T00:12:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/\"},\"wordCount\":917,\"publisher\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/AHE-Panel.png\",\"keywords\":[\"AHE Exchange26\",\"Environmental Services\",\"EVS\",\"Patient safety\",\"UV Regulation\",\"Whole Room Microbial Reduction\"],\"articleSection\":[\"Blog\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/\",\"name\":\"What Healthcare Leaders Need to Know About UV: 3 Takeaways from AHE Exchange26 - Surfacide\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/AHE-Panel.png\",\"datePublished\":\"2026-09-16T00:12:24+00:00\",\"dateModified\":\"2026-09-16T00:12:28+00:00\",\"description\":\"Show appreciation for environmental service employees by nominating them for our Surfacide Shining Star Scholarship Award.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/AHE-Panel.png\",\"contentUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/AHE-Panel.png\",\"width\":706,\"height\":613},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.surfacide.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What Healthcare Leaders Need to Know About UV: 3 Takeaways from AHE Exchange26\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#website\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/\",\"name\":\"http:\\\/\\\/www.surfacide.com\",\"description\":\"Surfacide\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.surfacide.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#organization\",\"name\":\"http:\\\/\\\/www.surfacide.com\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Surfacide-logo-1.png\",\"contentUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Surfacide-logo-1.png\",\"width\":263,\"height\":43,\"caption\":\"http:\\\/\\\/www.surfacide.com\"},\"image\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/surfacide\",\"https:\\\/\\\/x.com\\\/SurfacideUVC\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/surfacide-llc\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/person\\\/386a69d9460c5d653f83ad3b124557e9\",\"name\":\"Gina\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/307ff120af870bcfe24023f7a0befea0a28b3c542c05f604661725db930d372f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/307ff120af870bcfe24023f7a0befea0a28b3c542c05f604661725db930d372f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/307ff120af870bcfe24023f7a0befea0a28b3c542c05f604661725db930d372f?s=96&d=mm&r=g\",\"caption\":\"Gina\"},\"url\":\"https:\\\/\\\/www.surfacide.com\\\/es\\\/blog-news\\\/author\\\/ginatypeamarketing-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Lo que los l\u00edderes sanitarios deben saber sobre la radiaci\u00f3n UV: 3 conclusiones de AHE Exchange26 - Surfacide","description":"Demuestre su aprecio por los empleados del servicio medioambiental nomin\u00e1ndolos para nuestro premio de beca Surfacide Shining Star.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.surfacide.com\/es\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/","og_locale":"es_MX","og_type":"article","og_title":"What Healthcare Leaders Need to Know About UV: 3 Takeaways from AHE Exchange26","og_description":"Show appreciation for environmental service employees by nominating them for our Surfacide Shining Star Scholarship Award.","og_url":"https:\/\/www.surfacide.com\/es\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/","og_site_name":"Surfacide","article_publisher":"https:\/\/www.facebook.com\/surfacide","article_published_time":"2026-09-16T00:12:24+00:00","article_modified_time":"2026-09-16T00:12:28+00:00","og_image":[{"width":706,"height":613,"url":"http:\/\/www.surfacide.com\/wp-content\/uploads\/2026\/09\/AHE-Panel.png","type":"image\/png"}],"author":"Gina","twitter_card":"summary_large_image","twitter_creator":"@SurfacideUVC","twitter_site":"@SurfacideUVC","twitter_misc":{"Escrito por":"Gina","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/#article","isPartOf":{"@id":"https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/"},"author":{"name":"Gina","@id":"https:\/\/www.surfacide.com\/#\/schema\/person\/386a69d9460c5d653f83ad3b124557e9"},"headline":"What Healthcare Leaders Need to Know About UV: 3 Takeaways from AHE Exchange26","datePublished":"2026-09-16T00:12:24+00:00","dateModified":"2026-09-16T00:12:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/"},"wordCount":917,"publisher":{"@id":"https:\/\/www.surfacide.com\/#organization"},"image":{"@id":"https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/#primaryimage"},"thumbnailUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2026\/09\/AHE-Panel.png","keywords":["AHE Exchange26","Environmental Services","EVS","Patient safety","UV Regulation","Whole Room Microbial Reduction"],"articleSection":["Blog"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/","url":"https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/","name":"Lo que los l\u00edderes sanitarios deben saber sobre la radiaci\u00f3n UV: 3 conclusiones de AHE Exchange26 - Surfacide","isPartOf":{"@id":"https:\/\/www.surfacide.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/#primaryimage"},"image":{"@id":"https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/#primaryimage"},"thumbnailUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2026\/09\/AHE-Panel.png","datePublished":"2026-09-16T00:12:24+00:00","dateModified":"2026-09-16T00:12:28+00:00","description":"Demuestre su aprecio por los empleados del servicio medioambiental nomin\u00e1ndolos para nuestro premio de beca Surfacide Shining Star.","breadcrumb":{"@id":"https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/#primaryimage","url":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2026\/09\/AHE-Panel.png","contentUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2026\/09\/AHE-Panel.png","width":706,"height":613},{"@type":"BreadcrumbList","@id":"https:\/\/www.surfacide.com\/blog-news\/what-healthcare-leaders-need-to-know-about-uv-3-takeaways-from-ahe-exchange26\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.surfacide.com\/"},{"@type":"ListItem","position":2,"name":"What Healthcare Leaders Need to Know About UV: 3 Takeaways from AHE Exchange26"}]},{"@type":"WebSite","@id":"https:\/\/www.surfacide.com\/#website","url":"https:\/\/www.surfacide.com\/","name":"http:\/\/www.surfacide.com","description":"Surfacide","publisher":{"@id":"https:\/\/www.surfacide.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.surfacide.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.surfacide.com\/#organization","name":"http:\/\/www.surfacide.com","url":"https:\/\/www.surfacide.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.surfacide.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/06\/Surfacide-logo-1.png","contentUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/06\/Surfacide-logo-1.png","width":263,"height":43,"caption":"http:\/\/www.surfacide.com"},"image":{"@id":"https:\/\/www.surfacide.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/surfacide","https:\/\/x.com\/SurfacideUVC","https:\/\/www.linkedin.com\/company\/surfacide-llc"]},{"@type":"Person","@id":"https:\/\/www.surfacide.com\/#\/schema\/person\/386a69d9460c5d653f83ad3b124557e9","name":"Gina","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/307ff120af870bcfe24023f7a0befea0a28b3c542c05f604661725db930d372f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/307ff120af870bcfe24023f7a0befea0a28b3c542c05f604661725db930d372f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/307ff120af870bcfe24023f7a0befea0a28b3c542c05f604661725db930d372f?s=96&d=mm&r=g","caption":"Gina"},"url":"https:\/\/www.surfacide.com\/es\/blog-news\/author\/ginatypeamarketing-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/posts\/1980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/comments?post=1980"}],"version-history":[{"count":4,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/posts\/1980\/revisions"}],"predecessor-version":[{"id":1985,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/posts\/1980\/revisions\/1985"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/media\/1982"}],"wp:attachment":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/media?parent=1980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/categories?post=1980"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/tags?post=1980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}